Public

Talis Biomedical reached a settlement with $TLIS investors to resolve claims that it misled them about delays in approval and launch of the Talis One COVID-19 test. 

Talis Biomedical Corp

When will you be able to apply for the payment?

Talis Biomedical has only tentatively settled the case. The settlement amount and further information on filing claims will be known after the court approval.

Do I have to sell securities to be eligible?

No, if you have purchased securities within the class period, you are eligible to participate.

You can participate in the settlement and retain (or sell) your securities.

The entire process usually takes 4 to 9 months after the claim deadline. But the exact timing depends on the court and settlement administration.

11thestate is an investor recovery company, we help investors to track and collect securities class action settlements. We will:

Audit the claim and make sure you get the maximum possible payout.

File a claim with the settlement administration.

Correspond with the settlement administration to resolve emerging issues.

Deliver payout directly to your brokerage account.

There is no upfront cost, but we will deduct 20% of the recovered amount as a commission for our services.

Accepting Late Claims

Mismanagement

Misleading Statements

Omissions

Directors

Management

Research Entity

Talis Biomedical (TLIS) Investor Settlement

talisbiomedical-investor-settlement

Stocks

Long

Talis Biomedical Corporation operates as a molecular diagnostic company, focusing on developing medical devices for infectious diseases and other conditions at the point of care in the United States. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Chicago, Illinois.

Talis Biomedical (TLIS) Investor Settlement

Frequently Asked Questions